Journal of Cancer Research and Treatment
ISSN (Print): 2374-1996 ISSN (Online): 2374-2003 Website: Editor-in-chief: Jean Rommelaere
Open Access
Journal Browser
Journal of Cancer Research and Treatment. 2014, 2(2), 22-27
DOI: 10.12691/jcrt-2-2-1
Open AccessArticle

Quantitative DNA Assay (Ploidy), Koilocytotic Changes and AgNOR Expression for Risk Estimation in Oral Leukoplakia

Asoke Roy1, , Satyendra Prasad Bhatnagar2, Malay Chatterjee3, Goutam Mandal4 and Dipanwita Ghosh1

1Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, India

2Department of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi, India

3Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India

4Department of Pathology, Hospital Wing, Chittaranjan National Cancer Institute, Kolkata, India

Pub. Date: April 10, 2014

Cite this paper:
Asoke Roy, Satyendra Prasad Bhatnagar, Malay Chatterjee, Goutam Mandal and Dipanwita Ghosh. Quantitative DNA Assay (Ploidy), Koilocytotic Changes and AgNOR Expression for Risk Estimation in Oral Leukoplakia. Journal of Cancer Research and Treatment. 2014; 2(2):22-27. doi: 10.12691/jcrt-2-2-1


In this study, quantitative DNA estimation (DNA ploidy), AgNORs and koilocytotic changes were assessed in oral leukoplakia for risk categorization. Materials and methods: 50 cases of oral leukoplakias along with adequate controls were selected for the study. Quantitative DNA analysis was done by FACS scan. AgNORs were studied by silver staining method, koilocytotic changes and histopathology were studied in HE stained tissue sections. Results: Out of 50 cases, 45 cases (90%) were linked to traditional addiction of various forms and 5 cases (10%) were non-addicts. Histologically, there were 52% non dysplastic and 48% dysplastic cases. Out of these 50 cases, there were diploid, tetrapoid and aneuploid population including hypodiploid DNA content. The DNA index (DI), among these cases, were ranged from 0.22 (hypodiploid) to 2.12 (tetrapoid) (co-efficient of variation ranged from 0.39 to 18.43). The mean AgNOR count for smokers were 3.5 ± 2.058 whereas the mean AgNOR count for the betel quid group was 2.85 ± 1.47 and for khaini- gutka group was 3.67 ± 2.21. Less than 50% cases showed positivity for koilocytotic changes (20 out of 50 cases). Conclusion: The quantitative DNA (ploidy) study along with AgNORs can be considered dually as a prospective prognostic marker for cancer risk prediction in cases of oral leukoplakia. But koilocytotic changes for the HPV association as a marker for risk prediction in cases of oral leukoplakia is controversial and needs to be investigated on a large scale basis and follow up for a longer duration.

koilocytosis AgNORs DNA ploidy diploid tetraploid aneuploid hypodiploid dysplasia FACS HPV

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


Figure of 6


[1]  Flohr, J.K, Lee, J.H, “ Identical but different mechanism of cancer development and response to treatment for human papilloma virus-related and non related squamous cell cancer of the head and neck,” S D Med, 6,453-5, 2008.
[2]  Choudhury, A.K, Singh, M., Sudaram, S., et al., “Role of human Papiloma virus and its detection in potentially malignant head and neck lesions; updated review,” Head Neck Oncol, 1, 22, 2009.
[3]  Nooshin, M., Nasrollah, S., Noorieh, K., Mohammad, T.S., Shima, A.G., Setareh, S., “Evaluation of P53 and PCNA Expression in Oral Leukoplakic Lesions with and without Epithelial Dysplasia by Immunohistochemistry Technique,” J Mash Dent Sch, 33(2), 169-76, 2009.
[4]  Van Zyl, A.W., Van Heerden, M.B., Langenegger, E., Van Heerden, W.F.P., “Correlation between Dysplasia and Ploidy Status in Oral Leukoplakia,” Head and Neck Pathol, 6, 322-327, 2012.
[5]  Schepman, K., Van der, M.E.H., Smeele, L., et al., “Concomitant leukoplakia in patients with oral squamous cell carcinoma,” Oral Dis, 5, 206-9, 1999.
[6]  Lee, J.J., Hong, W.K., Hittelman, W.N., Lotan, L.R., Shin, D.M., et al., “Predicting cancer development in oral leukoplakia :ten years of translational research,” Clin Cancer Res, 6, 1702, 2000.
[7]  Manu, V., Rajaram, T., Rai, R., et al., “Value of Silver binding Nuclear Organizer Regions (AgNOR) in squamous cell of carcinoma of upper aero digestive tract,” MJAFI, 62, 123-8, 2006.
[8]  Pierre, R.V., “Cytogenetics in malignant lymphomas,” Virchows Arch B cell Pathol, 29, 107-12, 1978.
[9]  Seoane, J., Bascones, A., Asenjo, J.A., et al., “Flow cytometric analysis of nuclear DNA content in oral leukoplakia,” Clin Otolaryngal, 23, 136-40, 1998.
[10]  Costa, A.L., de Araujo, N.S., Pinto, D., et al., “PCNA / AgNOR and Ki 67/AgNOR double staining in Oral squamous cell carcinoma,” J Oral Pathol Med, 28, 438-4, 1999.
[11]  Howell, W.M., Selective staining of nucleolus organizer regions (NORs). In: Busch H and Rothblum L, Editors,1982, The Cell Nucleus Academic Press, New York, pp. 89-143.
[12]  Paiva, R.L., Sant’ Ana Filho, M., Bohrer, P.L., Lauxen Ida, S., Rados, P.V., “AgNOR quantification in cells of normal oral mucosa exposed to smoking and alcohol. A cytopathologic study,” Anal Quant Cytol Histol, 26,175-80, 2004.
[13]  Cancado, R.P., Yursel, L.S., Santanna, F., “Evaluation of the nuclear organizer regions associated proteins in exfoliative cytology of normal vocal misuse. Effect of smoking,” Oral Oncol, 37,446-54, 2001.
[14]  Shindoh, M., Chiba, I., Yasuda, M. et al., “Detection of human papillomavirus DNA sequence in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression,” Cancer, 76, 1513-1521, 1995.
[15]  Sugerman, P.B., Shillitoe, E.J., “The high risk human papillomaviruses and oral cancer: Evidence for and against a causal relationship,” Oral Dis, 3, 130-47, 1997.
[16]  Ploton, D., Menager, M., Jeannesson, P., Himber, G., Pigeon, F., Adnet, J.J., “Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level,” Histochem J, 18, 5-14, 1986.
[17]  Protocol of the University of Virginia last modified on November 25, 2003 [cited 2003 Nov 25] Available from:
[18]  McDermott, N., Suliman, Y., Bary Walsh, C., Kay, E.W., Curran, B., Milburn, C., et al., “Ploidy profile of morphologically normal squamous epithelium adjacent to high grade cervical intraepithelial neoplasia,” British Journal of Obstetrics and Gynaecology, 104, 623-625, 1997.
[19]  Sudbo, J., Kildal, W., Risberg, B., Koppang, H.S., Danielsen, H.E., Reith, A., “DNA content as a prognostic marker in patients with oral leukoplakia,” N Engl J Med, 344, 1270-8, 2001.
[20]  Fernandez, M.H., Bagan, J.V., Cortes, J.M., Roda, R.P., Calabuig, C., “The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma,” Oral Disease, 10, 346-348, 2004.
[21]  Orellana-Bustos, A.I., Espinoza-Santander, I.L., Franco-Martinez, M.E., Lobos-James-Freyre, N., Ortega-Pinto, A.V., “Evaluation of keratinisation and AgNORs count in exfoliative cytology of normal oral mucosa from smokers and non-smokers,” Med Oral, 9, 197-203, 2004.
[22]  Remmerbach, T.W., Weidenbach, H., Muller, C., et al., “Diagnostic value of nuclear organization (AgNORs) in brush biopsies of suspicious lesion of oral cavity,” Anal. Cell Pathol, 25,139-46, 2003.
[23]  Fontes, P.C., Correa, G.H.M., Issa, J.S., et al., “Comparison of exfoliative PAP stain and AgNOR counts of the tongue in smokers and non-smokers,” Head and Neck, 2, 157-162, 2008.
[24]  Kim, J.M., Adel-el-Naggar, D., Lee, J.S., Corrale, C., Lippman, S.S., Hong, W.K., et al., “Chromosome polysomy and Histological Characteristics in oral premalignant Lesions,” Cancer epidemiology, Biomarkers and Prevention, 10, 319-325, 2001.
[25]  Makari, D., Becker, J., Boecking, A., “Cytologic and DNA – cytometric very early diagnosis of oral cancer,” Anal Cell Pathol, 22, 211-21, 2001.